Skip to content

WHat is the impact of recurrent scabies on young people's daily lives?

Impact of recurrent scabies symptoms on the lives of young adults attending the scabies clinic in Amsterdam, the Netherlands - Impact of recurrent scabies symptoms on daily lives of young adults

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57514
Enrollment
60
Registered
2025-04-23
Start date
2025-06-19
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scabies, mite, Sarcoptes scabiei, parasitic mite

Interventions

Patients: 4 online questionnaires, which are sent at week 0, week 4, week 8 and week 12.&nbsp
Contacts: 2 online questionnaires, which are sent at week 0 and week 6. Questionnaires are validated PROMIS questionnaires supplemented with questions about the course of complaints and questions to e

Sponsors

GGD Amsterdam
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Dutch-speaking outpatients aged 18 up to and including 30 years old who were diagnosed with common scabies at the scabies clinic through clinical diagnosis and/or dermatoscopy, microscopy and/or PCR, starting a treatment with topical permethrin and/or oral ivermectin following their visit to the scabies clinic. To be eligible for an appointment at the scabies clinic patients need at least one previous consultation with a health professional for scabies and had undergone at least one (prescribed) treatment for scabies before. Contacts who are eligible for preventive treatment as described in the scabies guidelines by the National Coordination of Infectious Disease Control (LCI), and start one following their contacts’ diagnosis, were also included in the study, provided that they have been assessed and informed by the source- and contacttracing team of the GGD Amsterdam. 

Exclusion criteria

Exclusion criteria: Patients in whom no scabies was found during their consultation at the scabies clinic were excluded from participation in the study.Patients found positive on scabies but visited the clinic already before inclusionperiod of the research were excluded from study.Contacts that were eligible for preventive treatment but were not assessed by the GGD Amsterdam for various reasons, were excluded from participation in the study.

Design outcomes

Primary

MeasureTime frame
Change in PROMIS T-scores between week 12 and week 0 on different domains of Promis-29 V2.1

Secondary

MeasureTime frame
Patients' satisfaction score on 5-point Likert schalePatients' treatment adherence score on 5 point Likert schaleProportion of respondents indicating that received information was clear and actionable

Countries

Netherlands

Contacts

Public ContactI Valks

GGD Amsterdam

ivalks@ggd.amsterdam.nl0205555337

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)